Spanish experience with the ipilimumab Expanded Access Program.

被引：0
|
作者：
Berrocal, Alfonso
Lopez-Martin, Jose A.
Maria Arance, Ana
Soriano, V.
Espinosa, Enrique
Lopez Criado, M. Pilar
Munoz, Eva
Pablo Berros, Jose
Soria, A.
Marquez, I.
Sancho, P.
Gil, I.
机构：
[1] Univ Valencia, Consorcio Hosp Gen, Valencia, Spain
[2] Hosp 12 Octubre, E-28041 Madrid, Spain
[3] H Clin I Prov, Barcelona, Spain
[4] Inst Valenciano Oncol, Valencia, Spain
[5] Hosp Univ La Paz, Madrid, Spain
[6] MD Anderson Madrid, Madrid, Spain
[7] H Vall dHebron, Barcelona, Spain
[8] Hosp Univ Cent Asturias IUOPA, Oviedo, Spain
[9] Hosp Ramon & Cajal, E-28034 Madrid, Spain
[10] H Gregorio Maranon, Madrid, Spain
[11] Hosp Reina Sofia, Seville, Spain
[12] Hosp Reina Sofia, Navarra, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19023
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Canadian cohort expanded-access program of nivolumab plus ipilimumab in advanced melanoma
    Hogg, D.
    Monzon, J. G.
    Ernst, S.
    Song, X.
    McWhirter, E.
    Savage, K. J.
    Skinn, B.
    Romeyer, F.
    Smylie, M.
    CURRENT ONCOLOGY, 2020, 27 (04) : 204 - 214
  • [22] Project facilitate: A review of the FDA oncology center of excellence expanded access pilot program.
    Kormanik, Natasha L.
    Chan, Mitchell
    Boehmer, Jessica
    Kim, Tamy
    Blumenthal, Gideon Michael
    Pazdur, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Peritoneal dialysis (PD) access: Experience of an academic interventional nephrology (IN) program.
    Asif, A
    Byers, P
    Vieira, C
    Gadalean, F
    Pennell, P
    Castillo, J
    Hogan, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 393A - 393A
  • [24] Sequential Treatment with Ipilimumab and BRAF Inhibitors in Patients With Metastatic Melanoma: Data From the Italian Cohort of the Ipilimumab Expanded Access Program
    Ascierto, Paolo Antonio
    Simeone, Ester
    Sileni, Vanna Chiarion
    Del Vecchio, Michele
    Marchetti, Paolo
    Cappellini, Gian Carlo Antonini
    Ridolfi, Ruggero
    de Rosa, Francesco
    Cognetti, Francesco
    Ferraresi, Virginia
    Testori, Alessandro
    Queirolo, Paola
    Bernengo, Maria Grazia
    Guida, Michele
    Galli, Luca
    Mandala, Mario
    Cimminiello, Carolina
    Rinaldi, Gaetana
    Carnevale-Schianca, Fabrizio
    Maio, Michele
    CANCER INVESTIGATION, 2014, 32 (04) : 144 - 149
  • [25] Ipilimumab in the real world: The UK expanded access programme (EAP) experience in advanced melanoma.
    Ahmad, Saif
    Qian, Wendi
    Ellis, Sarah Gabrielle
    Khattak, Muhammad Adnan
    Gupta, Avinash
    Thillai, Kiruthikah
    Board, Ruth E.
    Nobes, Jenny
    Dalgleish, Angus
    Grumett, Simon Aird
    Maraveyas, Anthony
    Danson, Sarah
    Talbot, Toby
    Marples, Maria
    Plummer, Ruth
    Kumar, Satish
    Middleton, Mark R.
    Larkin, James M. G.
    Ottensmeier, Christian
    Corrie, Philippa
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] GECP 1605/NIVEX TRIAL nivolumab in the real world: The SPANISH expanded access program experience in pretreated advanced NSCLC
    Majem Tarruella, M.
    Campillo, J.
    Grau Bejar, J. F.
    Carcereny, E.
    Bernabe Caro, R.
    Garcia, Y.
    Artal-Cortes, A.
    Gonzalez Cao, M.
    Lianes, P.
    Paredes Lario, A.
    Sereno Moyano, M.
    Mielgo Rubio, X.
    Macias, J. A.
    Provencio Pulla, M.
    Rodriguez-Abreu, D.
    ANNALS OF ONCOLOGY, 2018, 29
  • [27] A two year experience with interventional nephrology peritoneal dialysis (PD) access program.
    Vieira, C
    Garces, G
    Gadalean, F
    Asif, A
    Schulman, I
    Groenhoff, C
    Hogan, R
    Roth, D
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 480A - 480A
  • [28] Spanish Melanoma Multidisciplinary Group (GEM): Longterm survivors treated with ipilimumab (IPI) in the expanded access programme (EAP).
    Hernando, Cristina
    Soriano, Virtudes
    Pablo Berros, Jose
    Maria Arance, Ana
    Mujika, Karmele
    Rodriguez Abreu, Delvys
    Alonso, Lorenzo
    Alonso, Martina
    Yapur, Lorena
    Berrocal, Alfonso
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Safety of trifluridine/tipiracil for metastatic colorectal cancer in African American patients participating in an expanded access program.
    Philip, Philip Agop
    Smaglo, Brandon George
    El-Rayes, Bassel F.
    Lesuisse, Christian
    Makris, Lukas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Efficacy and safety of infliximab treatment for refractory and fistulizing Crohn's disease in a Dutch expanded access program.
    van Hogezand, RA
    Russel, MG
    Naber, A
    Oldenburg, B
    Bodegraven, AA
    van Dulleman, HM
    Meijssen, MA
    Hurek, E
    Schaible, T
    Marks, SJ
    van Deventer, SJ
    GASTROENTEROLOGY, 2000, 118 (04) : A588 - A588
12345